Adil Abid Nawaz Khan, Hassan Muhammad, Khan Muhammad, Rahman Bakht, Raza Syed S, Varrassi Giustino
Internal Medicine, Community Medical Center, Fresno, USA.
Internal Medicine, University of Kansas Medical Center, Kansas City, USA.
Cureus. 2025 Mar 22;17(3):e80996. doi: 10.7759/cureus.80996. eCollection 2025 Mar.
Clear cell sarcoma (CCS) is a rare, aggressive soft tissue sarcoma with a strong predilection for the extremities. It is often misdiagnosed as melanoma. Despite surgical resection, CCS carries a high risk of early metastasis, most commonly to the lungs, bones, and lymph nodes, with limited effective systemic therapies available. We present the case of a 48-year-old man with CCS of the knee, initially presenting as a localized disease but rapidly progressing to widespread metastasis within three months. The patient underwent radical resection with knee arthroplasty and adjuvant radiotherapy, followed by systemic therapy with cabozantinib, ipilimumab, and nivolumab. Despite aggressive treatment, the disease progressed, leading to recurrent pleural effusions, respiratory failure, and, ultimately, the patient's demise within 10 months of diagnosis. This case underscores the highly aggressive nature of CCS and the challenges associated with its management. The rapid metastatic spread despite multimodal therapy highlights the need for improved early detection strategies and more effective systemic treatments, including novel targeted therapies and immunotherapy combinations.
透明细胞肉瘤(CCS)是一种罕见的侵袭性软组织肉瘤,极易发生于四肢。它常被误诊为黑色素瘤。尽管进行了手术切除,但CCS早期转移风险很高,最常见转移至肺、骨和淋巴结,而有效的全身治疗方法有限。我们报告一例48岁男性膝部CCS病例,最初表现为局限性疾病,但在三个月内迅速进展为广泛转移。患者接受了膝关节置换术根治性切除及辅助放疗,随后接受了卡博替尼、伊匹单抗和纳武单抗的全身治疗。尽管积极治疗,疾病仍进展,导致反复胸腔积液、呼吸衰竭,最终患者在确诊后10个月内死亡。该病例强调了CCS的高度侵袭性本质及其治疗挑战。尽管采取了多模式治疗,肿瘤仍迅速转移,这凸显了改进早期检测策略以及采用更有效全身治疗方法的必要性,包括新型靶向治疗和免疫治疗联合方案。